A non-controlled substance drug for ADHD: Intuniv (guanfacine) ER

Wednesday, September 9, 2009

Shire has announced that the FDA has approved Once-Daily INTUNIV (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17.

INTUNIV, the first nonscheduled alpha-2A receptor agonist indicated for Attention-Deficit/Hyperactivity Disorder (ADHD) demonstrated improvement in a range of ADHD symptoms that can be disruptive, such as inattention, arguing with adults, hyperactivity, impulsivity, and losing one's temper.

What's interesting is that INTUNIV is not a controlled substance by the DEA and has no known potential for abuse or dependence. Don't get this drug confused with guaifenesin (which is found in many common cold medicines). Look at how similar they are:
  • guanfacine
  • guaifenesin
OK, maybe they're not that similar, but if you have any problems with attention, then you may miss the obvious. Just call it Intuniv and I think you'll be safe from accidentally getting any of these guaifenesin products:
Anti-Tuss, Bidex, Breonesin, Duratuss G, Fenesin, Ganidin NR, GG 200 NR, Guaifenesin LA, Guaifenex G, Guaifenex LA, Humibid L.A., Humibid Pediatric, Liquibid, Muco-Fen 1200, Muco-Fen 800, Muco-Fen LA, Naldecon-EX Senior, Organidin NR, Pneumomist, Q-Bid LA, Robitussin, Scot-Tussin, Touro EX


One response to “A non-controlled substance drug for ADHD: Intuniv (guanfacine) ER”
Post a Comment | Post Comments (Atom)

Anonymous said...

I am currently a 15 y/o student in Indiana and I have recently been prescirbed Intuniv 4mg tablets. I find that Intuniv has worked with my attention and mood alot better than the other ADD/ADHD medication I was on: Concerta. Concerta had caused my heart rate to increase, increasing my anxiety. I have not had any of these side-effects with Intuniv. I am happy with the way this medication has worked.

December 7, 2010 at 1:20 PM

Post a Comment

About Dr. Joseph Kim

My Photo
Dr. Joseph Kim is the founder of MedicineandTechnology.com, an independent website owned and operated by Dr. Kim. He is also the President of MCM Education, a professional medical education and publishing company that develops continuing medical education (CME) activities in joint sponsorship with medical universities, hospitals, and medical associations.

Dr. Kim is a digital entrepreneur and technologist who has a passion for health information technology, mobile health, and social media. He frequently speaks at conferences about non-clinical careers for physicians, continuing medical education, mobile health technology, and social media in medicine. He is a regular contributor for the Physician Executive Journal, the official journal of the American College of Physician Executives.

Dr. Kim holds a bachelor of science in engineering from the Massachusetts Institute of Technology, a doctorate of medicine from the University of Arkansas College of Medicine, and a master of public health from the University of Massachusetts Amherst School of Public Health.
View my complete profile
Blog Widget by LinkWithin